Literature DB >> 16783204

Pretreatment of sivelestat sodium hydrate improves the lung microcirculation and alveolar damage in lipopolysaccharide-induced acute lung inflammation in hamsters.

Toshiaki Iba1, Akio Kidokoro, Masaki Fukunaga, Kitoji Takuhiro, Seiichiro Yoshikawa, Kiichi Sugimotoa.   

Abstract

Damage to the lung microcirculation and alveoli caused by activated leukocytes is known to play an important role in the development of acute lung injury (ALI). The aim of this study is to evaluate the difference in the effect of pretreatment and posttreatment of a synthetic neutrophil elastase inhibitor sivelestat on ALI. Hamsters were instilled with 10.0 mg/kg of lipopolysaccharide (LPS) intratracheally for 1 h to simulate ALI. Two milligrams per kilogram of sivelestat was injected intraperitoneally either previously or after LPS infusion. One and 24 hours after the infusion of LPS, pulmonary microcirculation was observed under the intravital microscopy. In another series, the blood cell counts were evaluated. The adhesive leukocyte count on the endothelium was significantly lower in pretreatment group compared with control group (P < 0.01), whereas the difference was not significant in the posttreatment group. Similarly, the number of obstructed capillary was significantly lower in the pretreatment group (P < 0.01). The width of interstitium was significantly lower in the pretreatment and posttreatment group (P < 0.01 and 0.05, respectively). A comparison of white blood cell counts showed a better maintenance in pretreatment group (P < 0.05). Pretreatment of sivelestat demonstrated a protective effect on both intravascular and extravascular damage in the lung, whereas posttreatment only suppressed the latter damage.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16783204     DOI: 10.1097/01.shk.0000223126.34017.d9

Source DB:  PubMed          Journal:  Shock        ISSN: 1073-2322            Impact factor:   3.454


  12 in total

1.  Inhibition of neutrophil elastase contributes to attenuation of lipopolysaccharide-induced acute lung injury during neutropenia recovery in mice.

Authors:  Jong Min Lee; Chang Dong Yeo; Hwa Young Lee; Chin Kook Rhee; In Kyoung Kim; Dong Gun Lee; Sang Haak Lee; Jin Woo Kim
Journal:  J Anesth       Date:  2017-01-31       Impact factor: 2.078

2.  The effect of the neutrophil elastase inhibitor sivelestat on early injury after liver resection.

Authors:  Shigehiro Tsujii; Takehiro Okabayashi; Mai Shiga; Yuka Takezaki; Takeki Sugimoto; Michiya Kobayashi; Kazuhiro Hanazaki
Journal:  World J Surg       Date:  2012-05       Impact factor: 3.352

3.  Effect of a selective neutrophil elastase inhibitor on mortality and ventilator-free days in patients with increased extravascular lung water: a post hoc analysis of the PiCCO Pulmonary Edema Study.

Authors:  Takashi Tagami; Ryoichi Tosa; Mariko Omura; Hidetada Fukushima; Tadashi Kaneko; Tomoyuki Endo; Hiroshi Rinka; Akira Murai; Junko Yamaguchi; Kazuhide Yoshikawa; Nobuyuki Saito; Hideaki Uzu; Yoichi Kase; Makoto Takatori; Hiroo Izumino; Toshiaki Nakamura; Ryutarou Seo; Yasuhide Kitazawa; Manabu Sugita; Hiroyuki Takahashi; Yuichi Kuroki; Takayuki Irahara; Takashi Kanemura; Hiroyuki Yokota; Shigeki Kushimoto
Journal:  J Intensive Care       Date:  2014-12-31

Review 4.  Role of Proteases in Chronic Obstructive Pulmonary Disease.

Authors:  Kailash C Pandey; Sajal De; Pradyumna K Mishra
Journal:  Front Pharmacol       Date:  2017-08-08       Impact factor: 5.810

5.  Clinical evaluation of sivelestat for acute lung injury/acute respiratory distress syndrome following surgery for abdominal sepsis.

Authors:  Yoshiaki Tsuboko; Shinhiro Takeda; Seiji Mii; Keiko Nakazato; Keiji Tanaka; Eiji Uchida; Atsuhiro Sakamoto
Journal:  Drug Des Devel Ther       Date:  2012-10-10       Impact factor: 4.162

6.  Oroxylin-A rescues LPS-induced acute lung injury via regulation of NF-κB signaling pathway in rodents.

Authors:  Tzu-Ling Tseng; Mei-Fang Chen; Ming-Jen Tsai; Yung-Hsiang Hsu; Chin-Piao Chen; Tony J F Lee
Journal:  PLoS One       Date:  2012-10-10       Impact factor: 3.240

7.  Usefulness of a selective neutrophil elastase inhibitor, sivelestat, in acute lung injury patients with sepsis.

Authors:  Seigo Miyoshi; Hironobu Hamada; Ryoji Ito; Hitoshi Katayama; Kazunori Irifune; Toshimitsu Suwaki; Norihiko Nakanishi; Takanori Kanematsu; Kentaro Dote; Mayuki Aibiki; Takafumi Okura; Jitsuo Higaki
Journal:  Drug Des Devel Ther       Date:  2013-04-10       Impact factor: 4.162

8.  Effect of hemoperfusion using polymyxin B-immobilized fibers on acute lung injury in a rat sepsis model.

Authors:  Toshiaki Iba; Isao Nagaoka; Atsushi Yamada; Masataka Nagayama; Takahiro Miki
Journal:  Int J Med Sci       Date:  2014-01-17       Impact factor: 3.738

9.  Combination therapy with sivelestat and recombinant human soluble thrombomodulin for ARDS and DIC patients.

Authors:  Seigo Miyoshi; Ryoji Ito; Hitoshi Katayama; Kentaro Dote; Mayuki Aibiki; Hironobu Hamada; Takafumi Okura; Jitsuo Higaki
Journal:  Drug Des Devel Ther       Date:  2014-09-02       Impact factor: 4.162

Review 10.  Coagulopathy in COVID-19.

Authors:  Toshiaki Iba; Jerrold H Levy; Marcel Levi; Jecko Thachil
Journal:  J Thromb Haemost       Date:  2020-07-21       Impact factor: 16.036

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.